Vanillin

Vanillin

SCHEMBL891130

CC(C)C(=O)O.COc1cc(C=O)ccc1O

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.78
HPGD P15428 2/20 0.78
TDP1 Q9NUW8 2/20 0.78
TRIM24 O15164 1/20 0.78
ALDH5A1 P51649 1/20 0.78
ABAT P80404 1/20 0.78
TRIM33 Q9UPN9 1/20 0.78
KDM4E B2RXH2 2/20 0.59
CA12 O43570 2/20 0.59
CA1 P00915 2/20 0.59
CA2 P00918 2/20 0.59
CA3 P07451 2/20 0.59
PKM P14618 2/20 0.59
CA4 P22748 2/20 0.59
CA6 P23280 2/20 0.59
CA5A P35218 2/20 0.59
SNCA P37840 2/20 0.59
CA7 P43166 2/20 0.59
CA9 Q16790 2/20 0.59
CA14 Q9ULX7 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Vanillin SCHEMBL27672925 0.97 ALDH1A1 (0.73) ALDH1A1HPGDTDP1TRIM24ALDH5A1
Vanillin SCHEMBL2878427 0.97 ALDH1A1 (0.73) ALDH1A1HPGDTDP1TRIM24ALDH5A1
Vanillin SCHEMBL20873445 0.92 ALDH1A1 (0.76) ALDH1A1HPGDTDP1TRIM24ALDH5A1
Ethyl Vanillin SCHEMBL28834487 0.91 ALDH1A1 (0.72) ALDH1A1HPGDTDP1TRIM24ALDH5A1
Vanillin SCHEMBL11005312 0.90 ALDH1A1 (0.89) ALDH1A1HPGDTDP1TRIM24ALDH5A1
Vanillin SCHEMBL29175199 0.90 ALDH1A1 (0.96) ALDH1A1HPGDTDP1TRIM24ALDH5A1
Vanillin SCHEMBL15772747 0.89 ALDH1A1 (0.86) ALDH1A1HPGDTDP1TRIM24ALDH5A1
Vanillin SCHEMBL81718 0.89 ALDH1A1 (0.86) ALDH1A1HPGDTDP1TRIM24ALDH5A1
Vanillin SCHEMBL4955213 0.89 ALDH1A1 (0.86) ALDH1A1HPGDTDP1TRIM24ALDH5A1
Vanillin SCHEMBL27845333 0.89 ALDH1A1 (0.93) ALDH1A1HPGDTDP1TRIM24ALDH5A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 651 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250302678-A1 ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS PROCTER & GAMBLE (US) 2025-10-02 US claimed
US-20250280857-A1 DEGRADATION-RESISTANT ALDEHYDE-CONTAINING COMPOSITIONS ZOOMESSENCE INC (US) 2025-09-11 US claimed
US-12350136-B2 Absorbent articles including perfume and cyclodextrins THE PROCTER & GAMBLE COMPANY (US) 2025-07-08 US claimed
WO-2025120502-A1 COMPOSITION OF CELLULOSE ESTER AND PLASTICIZER AND RELATED ARTICLE COMPRISING THE SAME LUXOTTICA S.R.L. (IT) 2025-06-12 WO claimed
US-20250129312-A1 CONSUMER PRODUCT COMPOSITIONS WITH PERFUME ENCAPSULATES PROCTER & GAMBLE (US) 2025-04-24 US claimed
US-20250059209-A1 THERAPEUTIC AGENTS AND USES THEREOF ANKH LIFE SCIENCES LIMITED (IE) 2025-02-20 US claimed
US-12209232-B2 Consumer product compositions with perfume encapsulates THE PROCTER & GAMBLE COMPANY (US) 2025-01-28 US claimed
EP-4438065-A2 A MIXTURE COMPRISING 1,2-ALKANEDIOLS Symrise AG (DE) 2024-10-02 EP claimed
EP-4356894-A1 SUSTAINABLE PRODUCT WITH MALODORS Beiersdorf AG (DE) 2024-04-24 EP claimed
WO-2023215706-A1 DEGRADATION-RESISTANT ALDEHYDE-CONTAINING COMPOSITIONS ZoomEssence, Inc. (US) 2023-11-09 WO claimed
US-20080249490-A1 Absorbent articles including an odor control system PROCTER & GAMBLE COMPANY, THE 2008-10-09 US claimed
EP-1942861-A2 MULTI-PHASE PERSONAL CARE COMPOSITION COMPRISING A STABILIZING PERFUME COMPOSITION The Procter and Gamble Company (US) 2008-07-16 EP claimed
US-20080071238-A1 Absorbent articles including an improved odor control system PROCTER & GAMBLE COMPANY, THE 2008-03-20 US claimed
WO-2008018044-A2 ABSORBENT ARTICLES INCLUDING AN IMPROVED ODOUR CONTROL SYSTEM THE PROCTER & GAMBLE COMPANY (US) 2008-02-14 WO claimed
EP-1886698-A1 Absorbent articles including an improved odour control system The Procter and Gamble Company (US) 2008-02-13 EP claimed
WO-2007113778-A2 ABSORBENT ARTICLES INCLUDING ODOUR CONTROL SYSTEM THE PROCTER & GAMBLE COMPANY (US) 2007-10-11 WO claimed
EP-1842565-A1 Absorbent articles including odour control system THE PROCTER & GAMBLE COMPANY (US) 2007-10-10 EP claimed
EP-1842564-A1 Absorbent articles including odour control system The Procter and Gamble Company (US) 2007-10-10 EP claimed
US-20070135319-A1 Multi-phase personal care composition comprising a stabilizing perfume composition PROCTER & GAMBLE COMPANY, THE 2007-06-14 US claimed
WO-2007052224-A2 MULTI-PHASE PERSONAL CARE COMPOSITION COMPRISING A STABILIZING PERFUME COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 2007-05-10 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135319-A1 Multi-phase personal care composition comprising a stabilizing perfume composition CUTA, PARG, POLG ALDH1A1 4123/4885HPGD 2955/4885TDP1 1121/4885
US-20250059209-A1 THERAPEUTIC AGENTS AND USES THEREOF MCL1, RNASE1, HNMT ALDH1A1 174/4885HPGD 2215/4885TDP1 1504/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.